Structure and function of matrix metalloproteinases and TIMPs

被引:2567
作者
Nagase, H
Visse, R
Murphy, G
机构
[1] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, Dept Matrix Biol, London W6 8LH, England
[2] Univ Cambridge, Dept Oncol, Cambridge Inst Med Res, Cambridge CB2 2XY, England
基金
英国惠康基金;
关键词
D O I
10.1016/j.cardiores.2005.12.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Matrix metalloproteinases (MMPs), also called matrixins, function in the extracellular environment of cells and degrade both matrix and non-matrix proteins. They play central roles in morphogenesis, wound healing, tissue repair and remodelling in response to injury, e.g. after myocardial infarction, and in progression of diseases such as atheroma, arthritis, cancer and chronic tissue ulcers. They are multi-domain proteins and their activities are regulated by tissue inhibitors of metalloproteinases (TIMPs). This review introduces the members of the MMP family and discusses their domain structure and function, proenyme activation, the mechanism of inhibition by TIMPs and their significance in physiology and pathology. (c) 2005 European Society of Cardiology. Published by Elsevier B.V All rights reserved.
引用
收藏
页码:562 / 573
页数:12
相关论文
共 114 条
[1]   Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-β1 in keratinocytes [J].
Ahokas, K ;
Lohi, J ;
Illman, SA ;
Llano, E ;
Elomaa, O ;
Impola, U ;
Karjalainen-Lindsberg, ML ;
Saarialho-Kere, U .
LABORATORY INVESTIGATION, 2003, 83 (12) :1887-1899
[2]   MATRIX METALLOPROTEINASE-2 IS AN INTERSTITIAL COLLAGENASE - INHIBITOR-FREE ENZYME CATALYZES THE CLEAVAGE OF COLLAGEN FIBRILS AND SOLUBLE NATIVE TYPE-I COLLAGEN GENERATING THE SPECIFIC 3/4-LENGTH AND 1/4-LENGTH FRAGMENTS [J].
AIMES, RT ;
QUIGLEY, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5872-5876
[3]  
ALLAN JA, 1991, J CELL SCI, V99, P789
[4]  
AMTSUMURA S, 2005, J CLIN INVEST, V115, P599
[5]   Palmitoylation at Cys574 is essential for MT1-MMP to promote cell migration [J].
Anilkumar, N ;
Uekita, T ;
Couchman, JR ;
Nagase, H ;
Seiki, M ;
Itoh, Y .
FASEB JOURNAL, 2005, 19 (08) :1326-+
[6]   Metalloproteinase inhibitors: biological actions and therapeutic opportunities [J].
Baker, AH ;
Edwards, DR ;
Murphy, G .
JOURNAL OF CELL SCIENCE, 2002, 115 (19) :3719-3727
[7]   STROMELYSIN-1 - 3-DIMENSIONAL STRUCTURE OF THE INHIBITED CATALYTIC DOMAIN AND OF THE C-TRUNCATED PROENZYME [J].
BECKER, JW ;
MARCY, AI ;
ROKOSZ, LL ;
AXEL, MG ;
BURBAUM, JJ ;
FITZGERALD, PMD ;
CAMERON, PM ;
ESSER, CK ;
HAGMANN, WK ;
HERMES, JD ;
SPRINGER, JP .
PROTEIN SCIENCE, 1995, 4 (10) :1966-1976
[8]  
Bigg HF, 2001, CANCER RES, V61, P3610
[9]   THE X-RAY CRYSTAL-STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN NEUTROPHIL COLLAGENASE INHIBITED BY A SUBSTRATE-ANALOG REVEALS THE ESSENTIALS FOR CATALYSIS AND SPECIFICITY [J].
BODE, W ;
REINEMER, P ;
HUBER, R ;
KLEINE, T ;
SCHNIERER, S ;
TSCHESCHE, H .
EMBO JOURNAL, 1994, 13 (06) :1263-1269
[10]   ASTACINS, SERRALYSINS, SNAKE-VENOM AND MATRIX METALLOPROTEINASES EXHIBIT IDENTICAL ZINC-BINDING ENVIRONMENTS (HEXXHXXGXXH AND MET-TURN) AND TOPOLOGIES AND SHOULD BE GROUPED INTO A COMMON FAMILY, THE METZINCINS [J].
BODE, W ;
GOMISRUTH, FX ;
STOCKLER, W .
FEBS LETTERS, 1993, 331 (1-2) :134-140